You H Bae
Hearing Aid Provider in Salt Lake City, UT

License number
Utah 7269911-8914
Issued Date
Feb 23, 2009
Expiration Date
Sep 30, 2013
Category
xControlled Substance Handler
Type
Controlled Substance Handler Individual
Address
Address
Salt Lake City, UT

Personal information

See more information about You H Bae at radaris.com
Name
Address
Phone
You Bae
1905 E Claybourne Ave, Salt Lake Cty, UT 84106
(801) 721-1643
You H Bae
1479 Devonshire Dr, Salt Lake City, UT 84108
(801) 474-1945
You H Bae, age 70
1711 Devonshire Dr, Salt Lake City, UT 84108
You H Bae
1905 Claybourne Ave, Salt Lake City, UT 84106
(801) 474-1945

Professional information

You Bae Photo 1

Implantable And Refillable Biohybrid Artificial Pancreas

US Patent:
5262055, Nov 16, 1993
Filed:
Oct 19, 1992
Appl. No.:
7/962879
Inventors:
You H. Bae - Salt Lake City UT
Sun W. Kim - Salt Lake City UT
Assignee:
The University of Utah - Salt Lake City UT
International Classification:
B01D 6100, B01D 6308, B01D 6906
US Classification:
210645
Abstract:
An artificial pancreas system which minimizes the volume of the artificial pancreas by not encapsulating each islet is taught wherein the islets are separated and held within a polymeric matrix which is soluble in an aqueous solution below body temperature but insoluble in aqueous solutions at or above body temperature. The polymer-islet mixture is contained in a pouch having access means such as entry and exit ports. The solubility makes it possible to replace the contents of the pouch by solubilizing the matrix simply by lowering the temperature below the LCST. The pouch is constructed of a biocompatible material permeable to insulin and other substances of similar or lesser molecular weight but is impermeable to cellular and humoral components of the body immune system. The islet-polymer matrix can be functionalized to stimulate insulin secretion from the islets using insulinotropic agents such as sulfonylurea. Also, polymeric microparticles which release bioactive agents which either promote vascularization at the pouch membrane outer surface or inhibit macrophage activity can be added to the polymer matrix.


You Bae Photo 2

Brachytherapy Seed With Fast Dissolving Matrix For Optimal Delivery Of Radionuclides To Cancer Tissue

US Patent:
2010005, Mar 4, 2010
Filed:
Sep 1, 2009
Appl. No.:
12/552190
Inventors:
Darrell R. Fisher - Richland WA, US
You Han Bae - Salt Lake City UT, US
Zhonggao Gao - Salt Lake City UT, US
Assignee:
Battelle Memorial Institute - Richland WA
University of Utah Research Foundation - Salt Lake City UT
International Classification:
A61M 36/12
US Classification:
600 8
Abstract:
A system, method and device for treating tumor cells utilizing a resorbable therapy seed made up of microspheres containing a beta- or alpha-particle-emitting radiation source and a resorbable polymer matrix. These seeds are implanted within the tumor and then rapidly dissolved so as to release the microspheres from the polymer matrix. These microspheres then spread within a preselected target area and provide radiation therapy in a predetermined amount and at a preselected rate according the specific needs and necessities of the users. The configuration of the microspheres, the types of radiation provided and the location and use of these microspheres provides desired localized treatment to target cells while preferentially avoiding or minimizing undesired damage to surrounding tissue. The present invention provides a method for making the seeds, as well as a method for utilizing the seeds as a part of the treatment method.


You Bae Photo 3

Brachytherapy Seed With Fast Dissolving Matrix For Optimal Delivery Of Radionuclides To Cancer Tissue

US Patent:
2010005, Mar 4, 2010
Filed:
Sep 2, 2008
Appl. No.:
12/202954
Inventors:
Darrell R. Fisher - Richland WA, US
You Han Bae - Salt Lake City UT, US
International Classification:
A61M 36/12
US Classification:
600 8
Abstract:
A system, method and device for treating tumor cells utilizing a resorbable therapy seed made up of microspheres containing a beta-particle-emitting radiation source and a resorbable polymer matrix. These seeds are implanted within the tumor and then rapidly dissolved or broken so as to release the microspheres. These microspheres then spread within a preselected target area and provide radiation therapy in a predetermined amount and at a preselected rate according the specific needs and necessities of the users. The configuration of the microspheres, the types of radiation provided and the location and use of these microspheres provides desired localized treatment to target cells while preferentially avoiding undesired damage to surrounding tissue. The present invention provides a method for making the seeds, as well as a method for utilizing the seeds as a part of the treatment method.


You Bae Photo 4

Pulsatile Drug Delivery Device Using Stimuli Sensitive Hydrogel

US Patent:
5226902, Jul 13, 1993
Filed:
Jul 30, 1991
Appl. No.:
7/737675
Inventors:
You H. Bae - Salt Lake City UT
Sung W. Kim - Salt Lake City UT
Lev I. Valuev - Moscow, SU
Assignee:
University of Utah - Salt Lake City UT
International Classification:
A61K 922
US Classification:
6048921
Abstract:
A device for the dispensing of a biologically active material into the surrounding environment is disclosed which consists of at least one wall enclosing a compartment which contains a swollen stimuli sensitive hydrogel in which the biologically active material is entrained in solution. The hydrogel deswells or shrinks in response to contact by external physical or chemical stimuli releasing the biologically active material into the portion of the compartment previously occupied by the swollen hydrogel. The wall enclosing the compartment is rigid and contains means allowing the passage of the biologically active material from the compartment to the surrounding environment and also for transmitting the external stimuli to the swollen hydrogel in said compartment. The wall may contain orifices or be permeable to the active material and external stimuli depending upon the drug and the stimuli to be used. The hydrogel reversibly deswells, shrinks or contracts in response to stimuli, such as temperature, pH, ionic strength, glucose concentration or metabolites in the body and then reswells and reentrains active material not diffused from the compartment when the stimuli is removed.


You Bae Photo 5

Ph-Sensitive Polymeric Micelles For Drug Delivery

US Patent:
7951846, May 31, 2011
Filed:
May 4, 2009
Appl. No.:
12/435283
Inventors:
You Han Bae - Salt Lake City UT, US
Kun Na - Salt Lake City UT, US
Eun Seong Lee - Salt Lake City UT, US
International Classification:
A61K 47/00, A61K 9/00, A01K 25/00
US Classification:
5147721, 424400, 514772
Abstract:
Mixed micelles containing poly(L-histidine)-poly(ethylene glycol) block copolymer and poly(L-lactic acid)-poly(ethylene glycol) block copolymer are a pH-sensitive drug carrier that release the drug in an acidic microenvironment, but not in the blood. Since the microenvironment of solid tumors is acidic, these mixed micelles are useful for treating cancer, including those cancers exhibiting multidrug resistance. Targeting ligands, such as folate, can also be attached to the mixed micelles for enhancing drug delivery into cells. Methods of treating a warm-blooded animal with such a drug are disclosed.


You Bae Photo 6

Polymersomes And Methods Of Making And Using Thereof

US Patent:
2011002, Feb 3, 2011
Filed:
Jul 28, 2009
Appl. No.:
12/510541
Inventors:
You Han Bae - Salt Lake City UT, US
Halqing Yin - San Lake City UT, US
International Classification:
A61K 9/127, C07C 233/01, C07K 7/06, C07K 7/08, C07K 14/00
US Classification:
424450, 564192, 530330, 530329, 530328, 530327, 530326, 530324, 530402
Abstract:
Described herein is the synthesis and pharmacology of polymersomes containing one or more bioactive agents. The polymersome is generally derived from a polymer having the formula XY, wherein X includes a hydrophilic group and Y includes a hydrophobic group. Also described herein are methods for making and using the polymersomes as drug delivery devices.


You Bae Photo 7

Ph And Temperature Sensitive Hydrogels

US Patent:
7786220, Aug 31, 2010
Filed:
Jan 26, 2005
Appl. No.:
10/590959
Inventors:
Doo Sung Lee - Gyeonggi-do, KR
Woo Sun Shim - Gyeonggi-do, KR
You Han Bae - Salt Lake City UT, US
Je Sun You - Gyeonggi-do, KR
Min Sang Kim - Gyeonggi-do, KR
Huynh Dai Phu - Gyeonggi-do, KR
Assignee:
Sungyunkwan University Foundation for Corporate Collaboration - Suwon-si
International Classification:
C08L 77/00
US Classification:
525408, 424426, 424486, 514601, 514602, 514603, 514604, 524609, 524612, 524916
Abstract:
The present invention relates to a block copolymer formed by coupling the following components with each other, as well as a hydrogel composition comprising the block copolymer and a hydrogel formed from the composition: (a) a copolymer of a polyethylene glycol (PEG)-based compound with a biodegradable polymer; and (b) a sulfonamide-based oligomer. The inventive block copolymer shows the sol-gel transition behavior sensitive to changes in not only temperature but also pH. Thus, the inventive block copolymer overcomes the shortcomings of temperature-sensitive copolymers, form a more strong and stable hydrogel, and is stable in vivo. Accordingly, the inventive block copolymer can be used in various applications in the medical and drug delivery fields.


You Bae Photo 8

Ph-Sensitive Polymeric Micelles For Drug Delivery

US Patent:
7659314, Feb 9, 2010
Filed:
May 14, 2004
Appl. No.:
10/846487
Inventors:
You Han Bae - Salt Lake City UT, US
Kun Na - Salt Lake City UT, US
Eun Seong Lee - Salt Lake City UT, US
Assignee:
University of Utah Research Foundation - Salt Lake City UT
International Classification:
A61K 47/00, A61K 9/00, A01K 25/00
US Classification:
5147721, 424400, 514772
Abstract:
Mixed micelles containing poly(L-histidine)-poly(ethylene glycol) block copolymer and poly(L-lactic acid)-poly(ethylene glycol) block copolymer are a pH-sensitive drug carrier that release the drug in an acidic microenvironment, but not in the blood. Since the microenvironment of solid tumors is acidic, these mixed micelles are useful for treating cancer, including those cancers exhibiting multidrug resistance. Targeting ligands, such as folate, can also be attached to the mixed micelles for enhancing drug delivery into cells. Methods of treating a warm-blooded animal with such a drug are disclosed.


You Bae Photo 9

Tumor Environment-Induced Ligand-Expressing Nanocarrier System

US Patent:
2008021, Sep 4, 2008
Filed:
Nov 30, 2007
Appl. No.:
11/998841
Inventors:
You Han Bae - Salt Lake City UT, US
Kun Na - Suwon, KR
Eun Seung Lee - Suwon, KR
International Classification:
A61K 9/14
US Classification:
424490
Abstract:
Drug delivery compositions for specific delivery of a drug to a tumor are described. These compositions include a core for sequestering the drug and a shell to which a ligand is attached for delivery of a drug to target cells. Since normal cells may also be targeted by the ligand, the compositions embed the ligand in the shell until the localized conditions surrounding the tumor cause the ligand to be displayed on the surface of the shell. One composition exhibits shrinkage of the shell at tumor pH, whereas another composition exhibits extension of the ligand at tumor pH. Still another composition causes the ligand to be exhibited at an elevated temperature.


You Bae Photo 10

Biosensor

US Patent:
6268161, Jul 31, 2001
Filed:
May 11, 1999
Appl. No.:
9/308392
Inventors:
In Suk Han - Salt Lake City UT
You Han Bae - Salt Lake City UT
Jules J. Magda - Salt Lake City UT
Seong Gi Baek - Woodbury MN
Assignee:
M-Biotech, Inc. - Salt Lake City UT
International Classification:
C12Q 154, C12M 134
US Classification:
435 14
Abstract:
A biosensor (10) has a pH-sensitive polymeric hydrogel (30) in a rigid and preferably biocompatible enclosure (20). The hydrogel (30) includes an immobilized oxidoreductase enzyme such as glucose oxidase. The oxidoreductase enzyme catalyzes a chemical reaction consuming an organic molecule and producing a byproduct. The hydrogel (30) changes its osmotic pressure in proportion to the concentration of a byproduct. By measuring the change in osmotic pressure with a pressure transducer (40), the biosensor (10) is able to accurately measure the concentration of the organic molecule without the problem of interference encountered by prior art biosensors. A battery (64) powered telemeter (60) operably engaged to the pressure transducer (40) sends a radio data signal to a receiver (66) operably attached to a computer (62).